Critical care, like many healthcare areas, is under a dual assault from significantly
increasing demographic and economic pressures. Intensive care unit (ICU) patients are …

Healthcare is under increasing demand pressure as societies age and expectations rise,
multiplied by increasing incidence of chronic diseases and decreasing available funding …

Continuous glucose monitoring (CGM) is well established in the management of diabetes
mellitus, but its role in neonatal glycaemic control is less clear. CGM has provided important …

Neonatal diabetes mellitus is a rare genetic disease that affects 1 in 90,000 live births. The
start of the disease is often before the baby is 6 months old, with rare cases of onset …

Computers and automation have revolutionised quality and productivity in many industries,
but not in medicine. Healthcare costs are thus growing beyond the ability of society to pay for …

Aim To study the outcomes of very preterm infants with hyperglycaemia treated with Insulin.
Methods This is a systematic review of randomised controlled trials (RCTs) and …

Abstract Model-based glycemic control (GC) protocols are used to treat stress-induced
hyperglycaemia in intensive care units (ICUs). The STAR (Stochastic-TARgeted) glycemic …

A number of adaptations in total parenteral nutrition (TPN) protocols and practices for
preterm neonates have been realized in the past several years, resulting in better survival …

Hyperglycaemia is a common problem in neonatal intensive care units (NICUs). Achieving
good control can result in better outcomes for patients. However, good control is difficult …

Preterm hyperglycaemia in the first 2 weeks of life is common under 29 weeks gestation and
is associated with increased mortality and morbidity. While the definition of hyperglycaemia …